|
ATP5A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.29920000038852E-07 |
| Normal-vs-Stage3 |
1.75759995446612E-09 |
| Normal-vs-Stage4 |
2.62279087337447E-12 |
| Stage1-vs-Stage2 |
8.128200E-01 |
| Stage1-vs-Stage3 |
1.218610E-01 |
| Stage1-vs-Stage4 |
8.455900E-02 |
| Stage2-vs-Stage3 |
3.852800E-01 |
| Stage2-vs-Stage4 |
1.610190E-01 |
| Stage3-vs-Stage4 |
5.777800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.87654361336354E-12 |
| Normal-vs-Asian |
4.43600045585413E-10 |
| Caucasian-vs-AfricanAmerican |
3.466800E-01 |
| Caucasian-vs-Asian |
2.325800E-01 |
| AfricanAmerican-vs-Asian |
1.884970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.59678953287812E-12 |
| Male-vs-Female |
1.186770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.2231996505725E-11 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.82054371578033E-12 |
| Normal-vs-Extreme_Obese |
1.382010E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.902200E-01 |
| Normal_Weight-vs-Obese |
7.293200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.481950E-01 |
| Extreme_Weight-vs-Obese |
6.821000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.721040E-01 |
| Obese-vs-Extreme_Obese |
1.106380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.55329999984977E-07 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.8773000000032E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.749200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.713200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.853000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.632400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.694200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.656400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.49029677487533E-11 |
| Normal-VS-KIRP CIMP |
1.62492241884138E-12 |
| Normal-VS-Unclassified PRCC |
2.69784194983913E-14 |
| Type1 PRCC-VS-Type2 PRCC |
9.959900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.462780E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.212000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.19590000000358E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.506210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.315770E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.68323166305618E-13 |
| Normal-vs-N1 |
1.81521464526213E-12 |
| Normal-vs-N2 |
1.47190004629039E-09 |
| N0-vs-N1 |
4.701800E-03 |
| N0-vs-N2 |
1.151600E-01 |
| N1-vs-N2 |
7.762200E-01 |
|
|
